← FDA DRUG APPROVALS

FDA ANDA · ANDA076775

GOOD SENSE NICOTINE

nicotine polacrilex

Sponsor: L PERRIGO CO

APPLICATION
ANDA076775
TYPE
ANDA
ORIGINAL APPROVAL
2004-09-16
LATEST ACTION
2024-03-15
ROUTE
ORAL, BUCCAL
DOSAGE FORM
GUM, CHEWING
MARKETING STATUS
Over-the-counter

Products

NICOTINE POLACRILEXOver-the-counter
NICOTINE POLACRILEX EQ 2MG BASE · GUM, CHEWING · BUCCAL

Approval history

2024-03-15Labeling · Supplement 31 · standardAP
2019-11-01Labeling · Supplement 24 · standardAP
2015-04-15Labeling · Supplement 22 · standardAP
2012-11-29Labeling · Supplement 21 · standardAP
2011-08-30Labeling · Supplement 18ReviewAP
2010-06-17Labeling · Supplement 16AP
2005-08-15Labeling · Supplement 2AP
2005-07-15Labeling · Supplement 1AP
2004-09-16OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →